@article{oai:nagasaki-u.repo.nii.ac.jp:00004491,
 author = {Otani, Yuki and Kawakami, Shigeru and Mukai, Hidefumi and Fuchigami, Yuki and Yamashita, Fumiyoshi and Hashida, Mitsuru},
 issue = {5},
 journal = {Journal of Drug Targeting},
 month = {Jun},
 note = {Background: Achieving long-term gene expression in kidney will be beneficial for gene therapy of renal and congenital diseases, genetic studies constructing animal disease models, and the functional analysis of disease-related genes. Purpose: The purpose of this study was to develop an in vivo long-term gene expression system in murine kidney using φC31 integrase. Methods: Gene expression in cultured RENCA, TCMK-1, and HEK293 cells was assessed. The long-term in vivo gene expression system in the kidney was achieved by co-transfecting 5 μg of pORF-luc/attB as a donor plasmid and 20 μg of pCMV-luc as a helper plasmid into the right kidney of mice by electroporation. Luciferase expression levels were measured to determine longevity of the expression. Results: Significantly high luciferase expression levels were observed in cultured RENCA, TCMK-1, and HEK293 cells over 1 month compared with controls (non-integrase system). The luciferase cDNA sequence was integrated at a pseudo attP site termed mpsL1. In vivo luciferase expression levels in the integrase group were sustained and significantly higher than those in the control group over 2 months. Furthermore, φC31 integrase-transfected cells had less genomic DNA damage caused by integrase expression. Discussion and conclusion: These results demonstrated that the φC31 integrase system could produce long-term (2 months) in vivo gene expression in mouse kidney., Journal of Drug Targeting, 23(5), pp.427-435; 2015},
 pages = {427--435},
 title = {Long-term in vivo gene expression in mouse kidney using φC31 integrase and electroporation},
 volume = {23},
 year = {2015}
}